ERBB2 and breast cancer: More recently, Baker et al.[110] showed that Notch1 contributes to sustain the trastuzumab resistance of HER2+ BC cells, by influencing the survival and tumor-initiating potential of BCSCs through the repression of PTEN, which results in the activation of the pro-proliferative ERK1/2 signaling.